BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 37199882)

  • 1. Complex Interplay Between Metabolism and CD4
    Yang J; Chen Y; Li X; Qin H; Bao J; Wang C; Dong X; Xu D
    Cardiovasc Drugs Ther; 2023 May; ():. PubMed ID: 37199882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic nexus of T cell immunometabolism in improving transplantation immunotherapy.
    Kazmi S; Khan MA; Shamma T; Altuhami A; Assiri AM; Broering DC
    Int Immunopharmacol; 2022 May; 106():108621. PubMed ID: 35189469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of lactate on metabolism and differentiation of CD4
    Zhang YT; Xing ML; Fang HH; Li WD; Wu L; Chen ZP
    Mol Immunol; 2023 Feb; 154():96-107. PubMed ID: 36621062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The AMP analog AICAR modulates the Treg/Th17 axis through enhancement of fatty acid oxidation.
    Gualdoni GA; Mayer KA; Göschl L; Boucheron N; Ellmeier W; Zlabinger GJ
    FASEB J; 2016 Nov; 30(11):3800-3809. PubMed ID: 27492924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PKM2-dependent metabolic reprogramming in CD4
    Lü S; Deng J; Liu H; Liu B; Yang J; Miao Y; Li J; Wang N; Jiang C; Xu Q; Wang X; Feng J
    J Mol Med (Berl); 2018 Jun; 96(6):585-600. PubMed ID: 29732501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory/effector T-cell ratio is reduced in coronary artery disease.
    Emoto T; Sasaki N; Yamashita T; Kasahara K; Yodoi K; Sasaki Y; Matsumoto T; Mizoguchi T; Hirata K
    Circ J; 2014; 78(12):2935-41. PubMed ID: 25327882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen-related receptor-α is a metabolic regulator of effector T-cell activation and differentiation.
    Michalek RD; Gerriets VA; Nichols AG; Inoue M; Kazmin D; Chang CY; Dwyer MA; Nelson ER; Pollizzi KN; Ilkayeva O; Giguere V; Zuercher WJ; Powell JD; Shinohara ML; McDonnell DP; Rathmell JC
    Proc Natl Acad Sci U S A; 2011 Nov; 108(45):18348-53. PubMed ID: 22042850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immuno-metabolic control of the balance between Th17-polarized and regulatory T-cells during HIV infection.
    Yero A; Bouassa RM; Ancuta P; Estaquier J; Jenabian MA
    Cytokine Growth Factor Rev; 2023 Feb; 69():1-13. PubMed ID: 36681548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory T Cells in Atherosclerosis: Is Adoptive Cell Therapy Possible?
    Churov AV; Chegodaev YS; Khotina VA; Ofitserov VP; Orekhov AN
    Life (Basel); 2023 Sep; 13(9):. PubMed ID: 37763334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation.
    Gerriets VA; Kishton RJ; Nichols AG; Macintyre AN; Inoue M; Ilkayeva O; Winter PS; Liu X; Priyadharshini B; Slawinska ME; Haeberli L; Huck C; Turka LA; Wood KC; Hale LP; Smith PA; Schneider MA; MacIver NJ; Locasale JW; Newgard CB; Shinohara ML; Rathmell JC
    J Clin Invest; 2015 Jan; 125(1):194-207. PubMed ID: 25437876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of immunosuppressive molecules on T-cell metabolic reprogramming.
    Fernández-Ramos AA; Poindessous V; Marchetti-Laurent C; Pallet N; Loriot MA
    Biochimie; 2016 Aug; 127():23-36. PubMed ID: 27126071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Ups and Downs of Metabolism during the Lifespan of a T Cell.
    Balyan R; Gautam N; Gascoigne NRJ
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33120978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4+ T cells in atherosclerosis: regulation by platelets.
    Li N
    Thromb Haemost; 2013 Jun; 109(6):980-90. PubMed ID: 23446374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4 T cells differentially express cellular machinery for serotonin signaling, synthesis, and metabolism.
    Wu H; Herr D; MacIver NJ; Rathmell JC; Gerriets VA
    Int Immunopharmacol; 2020 Nov; 88():106922. PubMed ID: 32866787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets.
    Michalek RD; Gerriets VA; Jacobs SR; Macintyre AN; MacIver NJ; Mason EF; Sullivan SA; Nichols AG; Rathmell JC
    J Immunol; 2011 Mar; 186(6):3299-303. PubMed ID: 21317389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatty Acid Synthase Contributes to Restimulation-Induced Cell Death of Human CD4 T Cells.
    Voss K; Luthers CR; Pohida K; Snow AL
    Front Mol Biosci; 2019; 6():106. PubMed ID: 31681794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune modulation of effector CD4+ and regulatory T cell function by sorafenib in patients with hepatocellular carcinoma.
    Cabrera R; Ararat M; Xu Y; Brusko T; Wasserfall C; Atkinson MA; Chang LJ; Liu C; Nelson DR
    Cancer Immunol Immunother; 2013 Apr; 62(4):737-46. PubMed ID: 23223899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunometabolism and systemic lupus erythematosus].
    Xiao YB; Guo MY; Zuo XX
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Dec; 50(6):1120-1124. PubMed ID: 30562794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of immune cell metabolism in health and disease: Special focus on T and B cell subsets.
    Chakraborty S; Khamaru P; Bhattacharyya A
    Cell Biol Int; 2022 Nov; 46(11):1729-1746. PubMed ID: 35900141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4
    Almeida L; Dhillon-LaBrooy A; Carriche G; Berod L; Sparwasser T
    J Allergy Clin Immunol; 2021 Jul; 148(1):16-32. PubMed ID: 33966898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.